US4563423A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Products displaying the antigenicity of hepatitis B virus e antigens and methods of producing those antigens
Assignee: Biogen Inc
•
Filing: 1982-09-02
•
Granted: 1986-01-07
•
Expires: 2002-09-02
Abstract
Abstract Polypeptides displaying the antigenicity of hepatitis B virus e antigens, DNA sequences coding for those polypeptides, antibodies to those polypeptides and methods of producing and using those polypeptides, antibodies and DNA sequences. The polypeptides and antibodies of this invention are characterized by their use in compositions and methods for detecting hepatitis B virus infective carriers and in evaluating the course of HBV-related active liver disease.
Inventors
- 👤 Kenneth Murray
- 👤 Patricia MacKay
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 13:05
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/576; G01N33/5761; C12; C12N; C12N2730/00; C12N2730/00011; C12N2730/10011; C12N2730/10111; C12N2730/10122; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/8215; Y10S435/822; Y10S435/848; Y10S435/849; Y10S530/00; Y10S530/806; Y10S530/81; Y10S530/82; Y10S530/825; Y10S530/826; Y10S930/00; Y10S930/01; Y10S930/22; Y10S930/223; Y10S930/31
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
88 words
A process for producing at least one polypeptide displaying the antigenicity of hepatitis B virus e antigens comprising the steps of: (a) preparing a bacterial extract of a host characterized by the expression of a polypeptide displaying the antigenicity of hepatitis B virus core antigen; and (b) digesting said extract with a reducing agent resistant protease in the presence of a reducing agent to convert the polypeptide displaying the antigenicity of hepatitis B virus core antigen into a polypeptide displaying the antigenicity of hepatitis B virus e antigens.
Claim 2
Dependent Claim
88 words
A process for producing at least one polypeptide displaying the antigenicity of hepatitis B virus e antigens comprising the steps of: (a) preparing a bacterial extract of a host characterized by the expression of a polypeptide displaying the antigenicity of hepatitis B virus core antigen; and (b) digesting said extract with a reducing agent resistant protease in the presence of a reducing agent to convert the polypeptide displaying the antigenicity of hepatitis B virus core antigen into a polypeptide displaying the antigenicity of hepatitis B virus e antigens.
Claim 3
Dependent Claim
29 words
The method of claim 1 wherein the protease is selected from the group consisting of pronase, subtilisin, carboxypeptidase A, carboxypeptidase B, papain, trypsin, chymopapain, bromelin, protease K, and thermolysin.
Claim 4
Dependent Claim
24 words
The method of claim 1 wherein the reducing agent is selected from the group consisting of 2-mercaptoethanol, dithiothreitol, glutathione, dithioerythritol, thioglycollate and sodium borohydride.
Claim 5
Dependent Claim
16 words
The method of claim 1 wherein the protease is pronase and the reducing agent is 2-mercaptoethanol.
Claim 6
Dependent Claim
94 words
A process for producing at least one polypeptide displaying the antigenicity of hepatitis B virus e antigens comprising the steps of: (a) preparing a bacterial extract of a host characterized by the expression of a polypeptide displaying the antigenicity of hepatitis B virus core antigen, said extract comprising about 60% of said hepatitis B virus core antigen; and (b) treating said extract with a reducing agent under dissociating conditions to convert the polypeptide displaying the antigenicity of hepatitis B virus core antigen into a polypeptide displaying the antigenicity of hepatitis B virus e antigens.
Claim 7
Dependent Claim
94 words
A process for producing at least one polypeptide displaying the antigenicity of hepatitis B virus e antigens comprising the steps of: (a) preparing a bacterial extract of a host characterized by the expression of a polypeptide displaying the antigenicity of hepatitis B virus core antigen, said extract comprising about 60% of said hepatitis B virus core antigen; and (b) treating said extract with a reducing agent under dissociating conditions to convert the polypeptide displaying the antigenicity of hepatitis B virus core antigen into a polypeptide displaying the antigenicity of hepatitis B virus e antigens.
Claim 8
Dependent Claim
21 words
The method of claim 5, wherein the reducing agent is 2-mercaptoethanol and the dissociating conditions are effected by sodium dodecyl sulfate.
References Cited (Backward Citations)
DE2049515A1
Cited
JPS5030671A
Cited
JPS50312A
Cited
US4118479A
Cited
US4164565A
Cited
US4021540A
Cited
US4138287A
Cited
US4102996A
Cited
FR2398504A1
Cited
US4197361A
Cited
BE875596A
Cited
EP0005864A1
Cited
US4164566A
Cited
US4162192A
Cited
US4204989A
Cited
EP0012686A1
Cited
GB2034323A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-01-06 | 1989-07-08 | 1990-01-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-01-06 | 1993-07-08 | 1994-01-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-01-06 | 1997-07-08 | 1998-01-07 | $7700.00 | Window Closed / Lapsed |